Professor Zhe Wang is one of the world’s leading innovators in stem cell biology and molecular immunology analytics. He has served as senior scientist to iRepertoire Inc, the company that pioneered commercial NGS-based sequencing of T- and B-cell repertoires for over ten years. More recently he was a Principal Investigator for Protein Drugs at China’s National Engineering Research Centre. He currently serves as Visiting Professor at the University of South China Centre of the Future, Distinguish Professor at Guangdong TCM hospital and Principal Investigator in Shanghai Cancer Research Centre, contributing to the frontier of translational longevity research. With more than 30 peer-reviewed publications and his own laboratories operating in both the US and China, Professor Wang has earned an international reputation for his groundbreaking work in immune-oncology and regenerative medicine.

‍